Measles eradication-retreating is not an option
- 1 June 2020
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 20 (6), E138-E141
- https://doi.org/10.1016/S1473-3099(20)30052-9
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Risk Factors for Measles Virus Infection Among Adults During a Large Outbreak in Postelimination Era in Mongolia, 2015The Journal of Infectious Diseases, 2017
- An increasing, potentially measles-susceptible population over time after vaccination in KoreaVaccine, 2017
- Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020Bulletin of the World Health Organization, 2017
- The price of delaying measles eradicationThe Lancet Public Health, 2017
- Countering the Zika epidemic in Latin AmericaScience, 2016
- Systematic Review of Health Economic Analyses of Measles and Rubella Immunization InterventionsRisk Analysis, 2014
- Measles – The epidemiology of eliminationVaccine, 2014
- Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance dataThe Lancet, 2012
- Proceedings of the Global Technical Consultation to Assess the Feasibility of Measles Eradication, 28–30 July 2010The Journal of Infectious Diseases, 2011
- The Rule of RescueSocial Science & Medicine (1982), 2003